| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Relay Therapeutics, Inc.'s insiders have reduced their positions by a net 8,660 shares worth roughly $162K.
RLAY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.45M | $28.67M | - | |
| Pres | 409.9K | $8.10M | - | |
| Other | 276.6K | $5.47M | - | |
| CFO | 213.9K | $4.23M | - | |
| Dir | 207.9K | $4.11M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | Bergstrom Donald A74 | President, R&D | Sale+OE | 4,900 | $25.46 | $124,754.00 | -5.2% | -29.0% | -55.9% | |
| Sep 1, 2022 | Bergstrom Donald A74 | President, R&D | Sale+OE | 8,100 | $23.07 | $186,867.00 | -8.3% | -25.4% | -55.7% | |
| Aug 24, 2022 | Bergstrom Donald A74 | President, R&D | Sale+OE | 15,000 | $25.00 | $375,000.00 | -14.3% | -28.3% | -62.0% | |
| Aug 5, 2022 | Bergstrom Donald A74 | President, R&D | Sale+OE | 8,000 | $20.00 | $160,000.00 | -8.2% | +6.1% | -43.0% | |
| Jul 28, 2022 | Porter Andy77 | Chief Administrative Officer | Sell | 452 | $21.27 | $9,614.04 | -1.0% | +7.8% | -40.1% | |
| Jul 28, 2022 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 734 | $21.26 | $15,604.84 | -1.4% | +7.8% | -40.1% | |
| Jul 28, 2022 | Bergstrom Donald A74 | President, R&D | Sell | 1,835 | $21.27 | $39,030.45 | -2.0% | +7.8% | -40.1% | |
| Jul 28, 2022 | Adams Brian71 | Chief Legal Officer | Sell | 734 | $21.27 | $15,612.18 | -1.2% | +7.8% | -40.1% | |
| Jul 6, 2022 | Bergstrom Donald A74 | President, R&D | Sale+OE | 8,000 | $20.00 | $160,000.00 | -8.0% | +17.9% | -44.7% | |
| Jun 27, 2022 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 300 | $20.31 | $6,093.00 | -0.6% | +17.9% | -32.7% |